I’ve been reflecting on the complexities of diagnosing neurodegenerative diseases, especially in early stages where symptoms can be subtle. Recently, I encountered a case of a patient with mild cognitive impairment that posed significant diagnostic challenges; utilizing advanced imaging techniques like PET scans and biomarker assessments is becoming crucial. I’m interested in discussing how others approach these intricate cases and what diagnostic tools have proven most effective in their practices.